Common Stock, Shares, Outstanding of Jade Biosciences, Inc. from 31 Dec 2020 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Jade Biosciences, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2020 to 31 Dec 2025.
  • Jade Biosciences, Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 49,316,287, a 1243% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Jade Biosciences, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 49,316,287 +45,643,493 +1243% 31 Dec 2025 10-K 06 Mar 2026 2025 FY
Q3 2025 32,626,730 +3,759,019 +13% 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 32,626,730 +3,771,980 +13% 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 28,985,019 +1,086,258 +3.9% 31 Mar 2025 10-Q 25 Apr 2025 2025 Q1
Q4 2024 3,672,794 -24,089,909 -87% 31 Dec 2024 10-K 06 Mar 2026 2025 FY
Q3 2024 28,867,711 +1,214,524 +4.4% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 28,854,750 +1,253,652 +4.5% 30 Jun 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 27,898,761 +3,081,821 +12% 31 Mar 2024 10-Q 13 May 2024 2024 Q1
Q4 2023 27,762,703 +3,039,729 +12% 31 Dec 2023 10-K 27 Mar 2025 2024 FY
Q3 2023 27,653,187 +3,146,797 +13% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 27,601,098 +3,182,664 +13% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 24,816,940 +406,547 +1.7% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 24,722,974 +312,581 +1.3% 31 Dec 2022 10-K 25 Mar 2024 2023 FY
Q3 2022 24,506,390 +95,997 +0.39% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 24,418,434 +24,175,358 +9946% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 24,410,393 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 24,410,393 +24,167,317 +9942% 31 Dec 2021 10-K 29 Mar 2023 2022 FY
Q3 2021 24,410,393 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 243,076 30 Jun 2021 10-Q 16 Aug 2021 2021 Q2
Q4 2020 243,076 31 Dec 2020 10-K 30 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.